Matthew Korenberg

2015

In 2015, Matthew Korenberg earned a total compensation of $2.8M as Vice President, Finance and Chief Financial Officer at Ligand Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$56,269
Option Awards$1,340,490
Salary$140,673
Stock Awards$1,255,080
Other$5,464
Total$2,797,976

Korenberg received $1.3M in option awards, accounting for 48% of the total pay in 2015.

Korenberg also received $56.3K in non-equity incentive plan, $140.7K in salary, $1.3M in stock awards and $5.5K in other compensation.

Rankings

In 2015, Matthew Korenberg's compensation ranked 3,414th out of 13,638 executives tracked by ExecPay. In other words, Korenberg earned more than 75.0% of executives.

ClassificationRankingPercentile
All
3,414
out of 13,638
75th
Division
Manufacturing
1,238
out of 5,190
76th
Major group
Chemicals And Allied Products
449
out of 1,854
76th
Industry group
Drugs
358
out of 1,528
77th
Industry
Pharmaceutical Preparations
285
out of 1,182
76th
Source: SEC filing on April 14, 2017.

Korenberg's colleagues

We found five more compensation records of executives who worked with Matthew Korenberg at Ligand Pharmaceuticals in 2015.

2015

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2015

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2015

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

2015

Charles Berkman

Ligand Pharmaceuticals

General Counsel

2015

Melanie Herman

Ligand Pharmaceuticals

Chief Financial Officer

News

You may also like